Member since: 2020
Organization: Anaheim Clinical Trials
Always saving the day!
Application Area: Diagnostic
"We are able to perform point of care COVID19 test in less than 20 minutes helping with our logistics."
The ID NOW™ COVID-19 assay is now available for use on the ID NOW platform under U.S. Food and Drug Administration Emergency Use Authorization (EUA). The ID NOW™ COVID-19 rapid test delivers high-quality molecular positive results in as little as 5 minutes, targeting the coronavirus (COVID-19) RdRp Gene.
Timely results enable healthcare professionals to make appropriate and more efficient treatment and infection control decisions. EUA supports flexible near-patient testing environments.